Promjene
Na 26. juni 2026., 15:25:15 UTC,
-
Nijedno polje nije ažurirano. Za više pojedinosti pogledajte promjenu metapodataka.
| f | 1 | { | f | 1 | { |
| 2 | "author": "Lyfeunit Ketamine Powder", | 2 | "author": "Lyfeunit Ketamine Powder", | ||
| 3 | "author_email": "inquiries.lyfeunit@proton.me", | 3 | "author_email": "inquiries.lyfeunit@proton.me", | ||
| 4 | "creator_user_id": "5ecc116b-5ec4-48f4-8366-afe5052790b1", | 4 | "creator_user_id": "5ecc116b-5ec4-48f4-8366-afe5052790b1", | ||
| 5 | "extras": [], | 5 | "extras": [], | ||
| 6 | "groups": [], | 6 | "groups": [], | ||
| 7 | "id": "140cb26d-eabb-4788-b8b2-3663063b0b3e", | 7 | "id": "140cb26d-eabb-4788-b8b2-3663063b0b3e", | ||
| 8 | "isopen": true, | 8 | "isopen": true, | ||
| 9 | "license_id": "other-at", | 9 | "license_id": "other-at", | ||
| 10 | "license_title": "Annan (Attribution)", | 10 | "license_title": "Annan (Attribution)", | ||
| 11 | "maintainer": "", | 11 | "maintainer": "", | ||
| 12 | "maintainer_email": "", | 12 | "maintainer_email": "", | ||
| 13 | "metadata_created": "2026-06-26T15:19:24.721888", | 13 | "metadata_created": "2026-06-26T15:19:24.721888", | ||
| n | 14 | "metadata_modified": "2026-06-26T15:25:15.471190", | n | 14 | "metadata_modified": "2026-06-26T15:25:15.672847", |
| 15 | "name": | 15 | "name": | ||
| 16 | grade-cas-1867-66-9-for-pharmaceutical-research-analytical-standards", | 16 | grade-cas-1867-66-9-for-pharmaceutical-research-analytical-standards", | ||
| 17 | "notes": "This dataset provides comprehensive information on | 17 | "notes": "This dataset provides comprehensive information on | ||
| 18 | Ketamine HCl Powder, a USP Grade (99.8% purity, CAS 1867-66-9) active | 18 | Ketamine HCl Powder, a USP Grade (99.8% purity, CAS 1867-66-9) active | ||
| 19 | pharmaceutical ingredient (API) suitable for advanced laboratory and | 19 | pharmaceutical ingredient (API) suitable for advanced laboratory and | ||
| 20 | analytical research. It details its applications in neuroscience, | 20 | analytical research. It details its applications in neuroscience, | ||
| 21 | refractory depression studies, pain management protocols, and as an | 21 | refractory depression studies, pain management protocols, and as an | ||
| 22 | analytical reference standard. Manufactured to exceed United States | 22 | analytical reference standard. Manufactured to exceed United States | ||
| 23 | Pharmacopeia (USP) standards, this pharmaceutical-grade compound | 23 | Pharmacopeia (USP) standards, this pharmaceutical-grade compound | ||
| 24 | ensures chemical integrity and consistency for researchers globally, | 24 | ensures chemical integrity and consistency for researchers globally, | ||
| 25 | including those affiliated with institutions like the University of | 25 | including those affiliated with institutions like the University of | ||
| 26 | Wollongong (UOW) and NIASRA.", | 26 | Wollongong (UOW) and NIASRA.", | ||
| 27 | "num_resources": 1, | 27 | "num_resources": 1, | ||
| 28 | "num_tags": 16, | 28 | "num_tags": 16, | ||
| 29 | "organization": null, | 29 | "organization": null, | ||
| 30 | "owner_org": null, | 30 | "owner_org": null, | ||
| 31 | "private": false, | 31 | "private": false, | ||
| 32 | "relationships_as_object": [], | 32 | "relationships_as_object": [], | ||
| 33 | "relationships_as_subject": [], | 33 | "relationships_as_subject": [], | ||
| 34 | "resources": [ | 34 | "resources": [ | ||
| 35 | { | 35 | { | ||
| 36 | "cache_last_updated": null, | 36 | "cache_last_updated": null, | ||
| 37 | "cache_url": null, | 37 | "cache_url": null, | ||
| 38 | "created": "2026-06-26T15:25:15.498277", | 38 | "created": "2026-06-26T15:25:15.498277", | ||
| 39 | "datastore_active": false, | 39 | "datastore_active": false, | ||
| 40 | "description": "This dataset provides technical and | 40 | "description": "This dataset provides technical and | ||
| 41 | pharmacological details for Ketamine HCl Powder, a USP Grade active | 41 | pharmacological details for Ketamine HCl Powder, a USP Grade active | ||
| 42 | pharmaceutical ingredient (API) with 99.8% purity. It is specifically | 42 | pharmaceutical ingredient (API) with 99.8% purity. It is specifically | ||
| 43 | curated for analytical research and clinical studies at institutions | 43 | curated for analytical research and clinical studies at institutions | ||
| 44 | like the University of Wollongong (UOW) and NIASRA.\r\n\r\nTechnical | 44 | like the University of Wollongong (UOW) and NIASRA.\r\n\r\nTechnical | ||
| 45 | Specifications\r\n\t\u2022\tChemical Name: Ketamine Hydrochloride | 45 | Specifications\r\n\t\u2022\tChemical Name: Ketamine Hydrochloride | ||
| 46 | (HCl)\r\n\t\u2022\tCAS Number: 1867-66-9\r\n\t\u2022\tPurity: 99.8% | 46 | (HCl)\r\n\t\u2022\tCAS Number: 1867-66-9\r\n\t\u2022\tPurity: 99.8% | ||
| 47 | Assay (Analytical Standard)\r\n\t\u2022\tGrade: USP / Pharmaceutical | 47 | Assay (Analytical Standard)\r\n\t\u2022\tGrade: USP / Pharmaceutical | ||
| 48 | Grade\r\n\t\u2022\tForm: Pure Crystalline Salt\r\n\r\nPrimary Research | 48 | Grade\r\n\t\u2022\tForm: Pure Crystalline Salt\r\n\r\nPrimary Research | ||
| 49 | Applications\r\n\t\u2022\tNeuroscience: Studying NMDA receptor | 49 | Applications\r\n\t\u2022\tNeuroscience: Studying NMDA receptor | ||
| 50 | modulation and glutamate signaling.\r\n\t\u2022\tPsychiatry: Research | 50 | modulation and glutamate signaling.\r\n\t\u2022\tPsychiatry: Research | ||
| 51 | into Treatment-Resistant Depression (TRD).\r\n\t\u2022\tPain | 51 | into Treatment-Resistant Depression (TRD).\r\n\t\u2022\tPain | ||
| 52 | Management: Clinical protocols for chronic and neuropathic | 52 | Management: Clinical protocols for chronic and neuropathic | ||
| 53 | pain.\r\n\t\u2022\tStandardization: Use as an analytical reference | 53 | pain.\r\n\t\u2022\tStandardization: Use as an analytical reference | ||
| 54 | standard for HPLC.\r\n\r\nHandling and Safety\r\n\t\u2022\tAlways use | 54 | standard for HPLC.\r\n\r\nHandling and Safety\r\n\t\u2022\tAlways use | ||
| 55 | nitrile gloves and N95-rated masks.\r\n\t\u2022\tCalibrate using | 55 | nitrile gloves and N95-rated masks.\r\n\t\u2022\tCalibrate using | ||
| 56 | scales with 0.001g precision.\r\n\t\u2022\tStore in a low-humidity | 56 | scales with 0.001g precision.\r\n\t\u2022\tStore in a low-humidity | ||
| 57 | environment between 20\u00b0C to 25\u00b0C.\r\n\r\nSource | 57 | environment between 20\u00b0C to 25\u00b0C.\r\n\r\nSource | ||
| 58 | Information\r\nFor detailed product specifications and procurement, | 58 | Information\r\nFor detailed product specifications and procurement, | ||
| 59 | visit:\r\nhttps://lyfeunit.com/product/buy-ketamine-powder/", | 59 | visit:\r\nhttps://lyfeunit.com/product/buy-ketamine-powder/", | ||
| 60 | "format": "", | 60 | "format": "", | ||
| 61 | "hash": "", | 61 | "hash": "", | ||
| 62 | "id": "61f64739-640a-4f63-9295-3aff0e28c8fc", | 62 | "id": "61f64739-640a-4f63-9295-3aff0e28c8fc", | ||
| 63 | "last_modified": "2026-06-26T15:25:15.465902", | 63 | "last_modified": "2026-06-26T15:25:15.465902", | ||
| n | 64 | "metadata_modified": "2026-06-26T15:25:15.477867", | n | 64 | "metadata_modified": "2026-06-26T15:25:15.676779", |
| 65 | "mimetype": null, | 65 | "mimetype": null, | ||
| 66 | "mimetype_inner": null, | 66 | "mimetype_inner": null, | ||
| 67 | "name": "Ketamine HCl Powder USP Grade (CAS 1867-66-9) Research | 67 | "name": "Ketamine HCl Powder USP Grade (CAS 1867-66-9) Research | ||
| 68 | Data", | 68 | Data", | ||
| 69 | "package_id": "140cb26d-eabb-4788-b8b2-3663063b0b3e", | 69 | "package_id": "140cb26d-eabb-4788-b8b2-3663063b0b3e", | ||
| 70 | "position": 0, | 70 | "position": 0, | ||
| 71 | "resource_type": null, | 71 | "resource_type": null, | ||
| 72 | "size": 84052, | 72 | "size": 84052, | ||
| 73 | "state": "active", | 73 | "state": "active", | ||
| 74 | "url": | 74 | "url": | ||
| 75 | 4f63-9295-3aff0e28c8fc/download/pure-ketamine-powder-online.jpg.webp", | 75 | 4f63-9295-3aff0e28c8fc/download/pure-ketamine-powder-online.jpg.webp", | ||
| 76 | "url_type": "upload" | 76 | "url_type": "upload" | ||
| 77 | } | 77 | } | ||
| 78 | ], | 78 | ], | ||
| t | 79 | "state": "draft", | t | 79 | "state": "active", |
| 80 | "tags": [ | 80 | "tags": [ | ||
| 81 | { | 81 | { | ||
| 82 | "display_name": "API", | 82 | "display_name": "API", | ||
| 83 | "id": "8525d629-627f-45d7-b577-5d5cef173c7a", | 83 | "id": "8525d629-627f-45d7-b577-5d5cef173c7a", | ||
| 84 | "name": "API", | 84 | "name": "API", | ||
| 85 | "state": "active", | 85 | "state": "active", | ||
| 86 | "vocabulary_id": null | 86 | "vocabulary_id": null | ||
| 87 | }, | 87 | }, | ||
| 88 | { | 88 | { | ||
| 89 | "display_name": "Analytical Standard", | 89 | "display_name": "Analytical Standard", | ||
| 90 | "id": "f18247bc-dcc1-4226-9b65-a253d8ef9f0f", | 90 | "id": "f18247bc-dcc1-4226-9b65-a253d8ef9f0f", | ||
| 91 | "name": "Analytical Standard", | 91 | "name": "Analytical Standard", | ||
| 92 | "state": "active", | 92 | "state": "active", | ||
| 93 | "vocabulary_id": null | 93 | "vocabulary_id": null | ||
| 94 | }, | 94 | }, | ||
| 95 | { | 95 | { | ||
| 96 | "display_name": "Anesthetic", | 96 | "display_name": "Anesthetic", | ||
| 97 | "id": "0c2a9579-1aca-4c5c-ae3c-48448fb489d7", | 97 | "id": "0c2a9579-1aca-4c5c-ae3c-48448fb489d7", | ||
| 98 | "name": "Anesthetic", | 98 | "name": "Anesthetic", | ||
| 99 | "state": "active", | 99 | "state": "active", | ||
| 100 | "vocabulary_id": null | 100 | "vocabulary_id": null | ||
| 101 | }, | 101 | }, | ||
| 102 | { | 102 | { | ||
| 103 | "display_name": "CAS 1867-66-9", | 103 | "display_name": "CAS 1867-66-9", | ||
| 104 | "id": "65e9d7bb-2917-42c6-a6e5-363a9c0c7b0c", | 104 | "id": "65e9d7bb-2917-42c6-a6e5-363a9c0c7b0c", | ||
| 105 | "name": "CAS 1867-66-9", | 105 | "name": "CAS 1867-66-9", | ||
| 106 | "state": "active", | 106 | "state": "active", | ||
| 107 | "vocabulary_id": null | 107 | "vocabulary_id": null | ||
| 108 | }, | 108 | }, | ||
| 109 | { | 109 | { | ||
| 110 | "display_name": "Data", | 110 | "display_name": "Data", | ||
| 111 | "id": "e0872c47-a8dc-4845-9d19-7cf661eb6120", | 111 | "id": "e0872c47-a8dc-4845-9d19-7cf661eb6120", | ||
| 112 | "name": "Data", | 112 | "name": "Data", | ||
| 113 | "state": "active", | 113 | "state": "active", | ||
| 114 | "vocabulary_id": null | 114 | "vocabulary_id": null | ||
| 115 | }, | 115 | }, | ||
| 116 | { | 116 | { | ||
| 117 | "display_name": "Depression Research", | 117 | "display_name": "Depression Research", | ||
| 118 | "id": "ad3a8d48-9463-4216-a2f8-44f7345aa108", | 118 | "id": "ad3a8d48-9463-4216-a2f8-44f7345aa108", | ||
| 119 | "name": "Depression Research", | 119 | "name": "Depression Research", | ||
| 120 | "state": "active", | 120 | "state": "active", | ||
| 121 | "vocabulary_id": null | 121 | "vocabulary_id": null | ||
| 122 | }, | 122 | }, | ||
| 123 | { | 123 | { | ||
| 124 | "display_name": "Ketamine", | 124 | "display_name": "Ketamine", | ||
| 125 | "id": "48f72ef9-0f48-4369-b9bb-d44cfd8cd822", | 125 | "id": "48f72ef9-0f48-4369-b9bb-d44cfd8cd822", | ||
| 126 | "name": "Ketamine", | 126 | "name": "Ketamine", | ||
| 127 | "state": "active", | 127 | "state": "active", | ||
| 128 | "vocabulary_id": null | 128 | "vocabulary_id": null | ||
| 129 | }, | 129 | }, | ||
| 130 | { | 130 | { | ||
| 131 | "display_name": "Ketamine HCl", | 131 | "display_name": "Ketamine HCl", | ||
| 132 | "id": "5e098923-ccd9-48f0-baea-6379fceae81a", | 132 | "id": "5e098923-ccd9-48f0-baea-6379fceae81a", | ||
| 133 | "name": "Ketamine HCl", | 133 | "name": "Ketamine HCl", | ||
| 134 | "state": "active", | 134 | "state": "active", | ||
| 135 | "vocabulary_id": null | 135 | "vocabulary_id": null | ||
| 136 | }, | 136 | }, | ||
| 137 | { | 137 | { | ||
| 138 | "display_name": "NIASRA", | 138 | "display_name": "NIASRA", | ||
| 139 | "id": "1b4af2e3-493f-4ee9-bfbc-30d31a49f0bf", | 139 | "id": "1b4af2e3-493f-4ee9-bfbc-30d31a49f0bf", | ||
| 140 | "name": "NIASRA", | 140 | "name": "NIASRA", | ||
| 141 | "state": "active", | 141 | "state": "active", | ||
| 142 | "vocabulary_id": null | 142 | "vocabulary_id": null | ||
| 143 | }, | 143 | }, | ||
| 144 | { | 144 | { | ||
| 145 | "display_name": "Neuroscience", | 145 | "display_name": "Neuroscience", | ||
| 146 | "id": "363dcbb4-e8bc-48c7-adc0-0572089a5e16", | 146 | "id": "363dcbb4-e8bc-48c7-adc0-0572089a5e16", | ||
| 147 | "name": "Neuroscience", | 147 | "name": "Neuroscience", | ||
| 148 | "state": "active", | 148 | "state": "active", | ||
| 149 | "vocabulary_id": null | 149 | "vocabulary_id": null | ||
| 150 | }, | 150 | }, | ||
| 151 | { | 151 | { | ||
| 152 | "display_name": "Pain Management", | 152 | "display_name": "Pain Management", | ||
| 153 | "id": "87654bcc-65ec-4163-b2f1-ce9df5b45fee", | 153 | "id": "87654bcc-65ec-4163-b2f1-ce9df5b45fee", | ||
| 154 | "name": "Pain Management", | 154 | "name": "Pain Management", | ||
| 155 | "state": "active", | 155 | "state": "active", | ||
| 156 | "vocabulary_id": null | 156 | "vocabulary_id": null | ||
| 157 | }, | 157 | }, | ||
| 158 | { | 158 | { | ||
| 159 | "display_name": "Pharmaceutical Grade", | 159 | "display_name": "Pharmaceutical Grade", | ||
| 160 | "id": "184bad88-3411-45d7-957e-11a377623017", | 160 | "id": "184bad88-3411-45d7-957e-11a377623017", | ||
| 161 | "name": "Pharmaceutical Grade", | 161 | "name": "Pharmaceutical Grade", | ||
| 162 | "state": "active", | 162 | "state": "active", | ||
| 163 | "vocabulary_id": null | 163 | "vocabulary_id": null | ||
| 164 | }, | 164 | }, | ||
| 165 | { | 165 | { | ||
| 166 | "display_name": "Pharmacology", | 166 | "display_name": "Pharmacology", | ||
| 167 | "id": "7b8a5e22-8b54-44a8-97e6-0fb830dde386", | 167 | "id": "7b8a5e22-8b54-44a8-97e6-0fb830dde386", | ||
| 168 | "name": "Pharmacology", | 168 | "name": "Pharmacology", | ||
| 169 | "state": "active", | 169 | "state": "active", | ||
| 170 | "vocabulary_id": null | 170 | "vocabulary_id": null | ||
| 171 | }, | 171 | }, | ||
| 172 | { | 172 | { | ||
| 173 | "display_name": "Research Chemical", | 173 | "display_name": "Research Chemical", | ||
| 174 | "id": "554a2c94-3368-4962-aaf0-bb470f6ebd7d", | 174 | "id": "554a2c94-3368-4962-aaf0-bb470f6ebd7d", | ||
| 175 | "name": "Research Chemical", | 175 | "name": "Research Chemical", | ||
| 176 | "state": "active", | 176 | "state": "active", | ||
| 177 | "vocabulary_id": null | 177 | "vocabulary_id": null | ||
| 178 | }, | 178 | }, | ||
| 179 | { | 179 | { | ||
| 180 | "display_name": "UOW", | 180 | "display_name": "UOW", | ||
| 181 | "id": "db7fb5f3-4f8e-45eb-ac60-18d37318f122", | 181 | "id": "db7fb5f3-4f8e-45eb-ac60-18d37318f122", | ||
| 182 | "name": "UOW", | 182 | "name": "UOW", | ||
| 183 | "state": "active", | 183 | "state": "active", | ||
| 184 | "vocabulary_id": null | 184 | "vocabulary_id": null | ||
| 185 | }, | 185 | }, | ||
| 186 | { | 186 | { | ||
| 187 | "display_name": "USP Grade", | 187 | "display_name": "USP Grade", | ||
| 188 | "id": "a6ff46c0-e9d0-4a0a-a2e1-029ff59797a4", | 188 | "id": "a6ff46c0-e9d0-4a0a-a2e1-029ff59797a4", | ||
| 189 | "name": "USP Grade", | 189 | "name": "USP Grade", | ||
| 190 | "state": "active", | 190 | "state": "active", | ||
| 191 | "vocabulary_id": null | 191 | "vocabulary_id": null | ||
| 192 | } | 192 | } | ||
| 193 | ], | 193 | ], | ||
| 194 | "title": "Ketamine HCl Powder USP Grade (CAS 1867-66-9) for | 194 | "title": "Ketamine HCl Powder USP Grade (CAS 1867-66-9) for | ||
| 195 | Pharmaceutical Research & Analytical Standards", | 195 | Pharmaceutical Research & Analytical Standards", | ||
| 196 | "type": "dataset", | 196 | "type": "dataset", | ||
| 197 | "url": "https://lyfeunit.com/product/buy-ketamine-powder/", | 197 | "url": "https://lyfeunit.com/product/buy-ketamine-powder/", | ||
| 198 | "version": "" | 198 | "version": "" | ||
| 199 | } | 199 | } |